AAP
29
-6
VZ
47
-2
PCAR
34
-8
SEE
42
-8
AXP
60
-7
PFE
46
-5
ADBE
47
-9
O
53
-2
ALLE
30
-11
HAL
44
4
CRM
27
-7
AMG
55
-3
SRE
45
-7
EIX
34
-6
ILMN
46
-3
NKE
24
-4
FIS
55
-8
HCA
55
-2
FMC
29
-8
FE
53
-3
AAP
29
-6
VZ
47
-2
PCAR
34
-8
SEE
42
-8
AXP
60
-7
PFE
46
-5
ADBE
47
-9
O
53
-2
ALLE
30
-11
HAL
44
4
CRM
27
-7
AMG
55
-3
SRE
45
-7
EIX
34
-6
ILMN
46
-3
NKE
24
-4
FIS
55
-8
HCA
55
-2
FMC
29
-8
FE
53
-3
Financhill
Back

NewLake Capital Partners Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
39

NLCP
NewLake Capital Partners

Last Price:
$14.86
Seasonality Move:
-4.5%
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
$18.84
Seasonality Move:
-0.62%
Sell
39
NewLake Capital Partners (NLCP) is a Sell

Is NewLake Capital Partners a Buy, Sell or Hold?

  • The current NewLake Capital Partners [NLCP] share price is $14.86. The Score for NLCP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NLCP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $18.83. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NLCP Stock Price Chart

What is NewLake Capital Partners's stock price today?

  • The NewLake Capital Partners share price today is $14.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLCP is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $18.83
    The current trend is relatively stagnant and APLS is experiencing slight selling pressure.

NLCP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 58 Buy
Chaikin Money Flow: -19890 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.3 - 14.84) Buy
Bollinger Bands (100): (14.07 - 16.03) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 51.68 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.04 - 19.02) Buy
Bollinger Bands (100): (18.02 - 27.22) Sell

NLCP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.67 Buy
20-day SMA: 14.58 Buy
50-day SMA: 14.3 Buy
200-day SMA: 17.05 Sell
8-day EMA: 14.71 Buy
20-day EMA: 14.6 Buy
50-day EMA: 14.65 Buy
200-day EMA: 16.19 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.15 Sell
20-day SMA: 18.27 Buy
50-day SMA: 18.45 Buy
200-day SMA: 27.26 Sell
8-day EMA: 19 Sell
20-day EMA: 18.61 Buy
50-day EMA: 19.47 Sell
200-day EMA: 27.34 Sell

NewLake Capital Partners Earnings Growth & NLCP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.13 per share, and an increase next year of $0.07 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

NewLake Capital Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):